-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Worldwide, colorectal cancer (CRC) is the second most common cancer in women and the third most common cancer in men, causing more than 690,000 deaths in 2012
.
In the United States, CRC is the second leading cause of cancer death, accounting for approximately 8.
Worldwide, colorectal cancer (CRC) is the second most common cancer in women and the third most common cancer in men, causing more than 690,000 deaths in 2012
About 53% of the reduction in CRC mortality observed with screening prevention may have been attributed to CRC screening .
Digestive immunity
The researchers conducted a randomized controlled trial (SCREESCO) in Sweden
.
In 18 of 21 districts, residents who turned 60 years of age in the year of randomization were randomly assigned to have only one colonoscopy, two rounds of fecal immunochemical testing (OC-Sensor; 2 years apart), or Control group (no intervention; standard diagnostic approach)
diagnosis
Between March 1, 2014, and December 31, 2020, 278,280 people were included in the study; 31,140 were assigned to colonoscopy, 60,300 to stool immunochemistry, and 186,840 to controls group
.
Of the 30,400 people who received an invitation to a colonoscopy, 10,679 (35.
1%) participated
Of the 30,400 people who received an invitation to a colonoscopy, 10,679 (35.
In an intention-to-treat analysis, colon cancer was detected in 49 of 31,140 people (0.
It can be seen that only one colonoscopy and two stool immunochemical screening screenings can be used for CRC screening services in the population
.
.
It can be seen that only one colonoscopy and two stool immunochemical screening screenings can be used for CRC screening services in the population
references:
Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
https://doi.
org/10.
1016/S2468-1253(21)00473-8Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
Leave a comment here
